Key Statistics for 1789
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (TWD) (ttm)
|Est. EPS (TWD) (12/2013)
|Est. PEG Ratio
|Market Cap (M TWD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (TWD)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 1789
- Net Income (M/TWD)
ScinoPharm Taiwan Ltd. offers process research and development and the production of active pharmaceutical ingredients. The Company provides services to pharmaceutical industries globally.
More Company Profile & Key Executives for 1789
|Cheng Kao-HuiChairman||Jo ShenPresident/CEO|
|Chou Patricia PeifenVP:Planning/CFO||Chen Yung-FaVP:R&D Center|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.